Progesterone
Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women, Treatment of secondary amenorrhea
Indications
- Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women
- Treatment of secondary amenorrhea
Adult dosing
- endometrial hyperplasia: dose: 200; unit: mg; route: PO; interval: daily at bedtime for 12 days per 28-day cycle; fixed: true; labelExcerpt: PROMETRIUM Capsules should be given as a single daily dose at bedtime, 200 mg orally for 12 days sequentially per 28-day cycle, to a postmenopausal woman with a uterus who is receiving daily conjugated estrogens tablets.
- secondary amenorrhea: dose: 400; unit: mg; route: PO; interval: daily at bedtime for 10 days; fixed: true; labelExcerpt: PROMETRIUM Capsules may be given as a single daily dose of 400 mg at bedtime for 10 days.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Peanut allergy
- Abnormal genital bleeding
- Breast cancer
- Active DVT/PE
- Active arterial thromboembolic disease
Clinical pearls
- Take at bedtime; if difficulty swallowing, take with water while standing.
- Contains peanut oil; contraindicated in patients with peanut allergy.
- Concomitant food ingestion increases bioavailability.
- Discontinue immediately if thromboembolic events (PE, DVT, stroke, MI) occur.
Source and review
- DailyMed label (progesterone, Prometrium), Set ID 1cf237ff-c4f8-4faa-a7aa-77599c856889, effective 2026-07-23. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties